Literature DB >> 23744953

The analgesic efficacy of subcostal transversus abdominis plane block compared with thoracic epidural analgesia and intravenous opioid analgesia after radical gastrectomy.

Yiquan Wu1, Fuli Liu, Hongli Tang, Quanguang Wang, Limei Chen, Hui Wu, Xuezheng Zhang, Jianxia Miao, Meizhen Zhu, Chenggang Hu, Mark Goldsworthy, Jing You, Xuzhong Xu.   

Abstract

BACKGROUND: The transversus abdominis plane (TAP) block has been shown to provide effective postoperative analgesia in lower abdominal surgery. Subcostal TAP block has also been proposed as a new technique to provide analgesia for the supraumbilical abdomen. We compared the analgesic and opioid-sparing effects of a single-injection subcostal TAP block with continuous thoracic epidural analgesia and IV opioid analgesia.
METHODS: Ninety patients undergoing elective radical gastrectomy were randomized to receive either combined general-subcostal TAP anesthesia (group TAP), combined general-epidural anesthesia (group EA), or general anesthesia (group GA), and were analyzed on an intention-to-treat basis. In group TAP, a bilateral subcostal TAP block was performed after induction of general anesthesia using 20 mL of 0.375% ropivacaine. In group EA, a thoracic epidural was placed between T8 and T9 and bolused with 8 mL of 0.25% ropivacaine before induction of general anesthesia. The epidural was maintained with 5 mL/h of 0.25% ropivacaine during the surgery. Group GA received standard general anesthesia. In the postanesthesia care unit (PACU), all groups received IV morphine titration for visual analog scale (VAS) pain scores >3. All patients were started on IV patient-controlled analgesia with morphine after morphine titration in the PACU, while group EA also had their epidural maintained with 5 mL/h of 0.125% bupivacaine with 8 μg/mL morphine. Patients were assessed in the PACU and at 1, 3, 6, 24, 48, and 72 hours postoperatively. Primary outcomes measured were morphine consumption at 24 hours and all VAS pain scores.
RESULTS: Data from 82 of 90 (91.1%) patients were included in the study. Group TAP demonstrated decreased cumulative morphine consumption at 24 hours (98.75% confidence intervals, -29 to -9 mg) and noninferiority on VAS pain scores at all measurement times, as compared with group GA with standard opioid analgesia. However, group EA was superior to group TAP regarding cumulative morphine consumption at 24 hours (98.75% confidence intervals, -23 to -4 mg) and noninferior to group TAP on VAS pain scores at all comparison points. Group TAP had reduced morphine consumption from PACU admission to 6 hours as compared with group GA, but increased morphine consumption for 6 to 24 hours as compared with group EA.
CONCLUSION: Single-injection subcostal TAP block was more effective than IV opioid analgesia, while continuous thoracic epidural analgesia was more effective than the single-injection subcostal TAP block.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23744953     DOI: 10.1213/ANE.0b013e318297fcee

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  26 in total

1.  The efficacy of continuous subcostal transversus abdominis plane block for analgesia after living liver donation: a retrospective study.

Authors:  Akihiko Maeda; Sho Carl Shibata; Hiroshi Wada; Shigeru Marubashi; Takahiko Kamibayashi; Hidetoshi Eguchi; Yuji Fujino
Journal:  J Anesth       Date:  2015-10-28       Impact factor: 2.078

Review 2.  New Cancer Pain Treatment Options.

Authors:  Kenneth D Candido; Teresa M Kusper; Nebojsa Nick Knezevic
Journal:  Curr Pain Headache Rep       Date:  2017-02

3.  Enhanced Recovery via Peripheral Nerve Block for Open Hepatectomy.

Authors:  Lucas W Thornblade; Yongwoo D Seo; Tracy Kwan; Jane H Cardoso; Eric Pan; Gregory Dembo; Raymond S W Yeung; James O Park
Journal:  J Gastrointest Surg       Date:  2018-02-05       Impact factor: 3.452

Review 4.  Clinical safety and effectiveness of transversus abdominis plane (TAP) block in post-operative analgesia: a systematic review and meta-analysis.

Authors:  Ning Ma; Joanna K Duncan; Anje J Scarfe; Susanne Schuhmann; Alun L Cameron
Journal:  J Anesth       Date:  2017-03-07       Impact factor: 2.078

5.  Comparison of the analgesic effect between continuous wound infiltration and single-injection transversus abdominis plane block after gynecologic laparotomy.

Authors:  Kunihisa Hotta; Soichiro Inoue; Koki Taira; Naho Sata; Kenji Tamai; Mamoru Takeuchi
Journal:  J Anesth       Date:  2015-10-14       Impact factor: 2.078

6.  Ultrasound-guided erector spinae plane block for pain management after gastrectomy: a randomized, single-blinded, controlled trial.

Authors:  Heejoon Jeong; Ji Won Choi; Woo Seog Sim; Duk Kyung Kim; Yu Jeong Bang; Soyoon Park; Hyean Yeo; Hara Kim
Journal:  Korean J Pain       Date:  2022-07-01

7.  Transversus abdominis plane block versus local anaesthetic wound infiltration for postoperative analgesia: A systematic review and meta-analysis.

Authors:  Qingduo Guo; Rui Li; Lixian Wang; Dong Zhang; Yali Ma
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  Application of ultrasound-guided subcostal transversus abdominis plane block in gastric cancer patients undergoing open gastrectomy.

Authors:  Kai Li; Longyun Li; Ming Gao; Zhihua Zhu; Peng Chen; Li Yang; Guoqing Zhao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 9.  Transversus abdominal plane block for postoperative analgesia: a systematic review and meta-analysis of randomized-controlled trials.

Authors:  Etrusca Brogi; Roy Kazan; Shantale Cyr; Francesco Giunta; Thomas M Hemmerling
Journal:  Can J Anaesth       Date:  2016-06-15       Impact factor: 6.713

10.  Analgesia and respiratory function after laparoscopic cholecystectomy in patients receiving ultrasound-guided bilateral oblique subcostal transversus abdominis plane block: a randomized double-blind study.

Authors:  Betul Basaran; Ahmet Basaran; Betul Kozanhan; Ela Kasdogan; Mehmet Ali Eryilmaz; Sadik Ozmen
Journal:  Med Sci Monit       Date:  2015-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.